Global Piriformis Syndrome Treatment Market, By Treatment (Medication, Physical Therapy, Osteopathic Manipulative Treatment (OMT), Prolotherapy, Surgery, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2029.
Piriformis Syndrome Treatment Market Analysis and Size
The global piriformis syndrome treatment market is expected to witness significant growth during the forecast period. According to the National Center for Biotechnology Information (NCBI) records, piriformis syndrome is more widespread in patients with pain in the lower back. Although the cause of piriformis syndrome is unknown; but, some probable causes are irritation in the piriformis muscles or in the sacroiliac joint or hip, tightening or swelling of the muscles in response to or due to injury or spasm or in some cases, bleeding in the piriformis muscle area. Sudden outbreak of the COVID-19 pandemic imposed stringent lockdown regulations globally, causing interruptions in import and export activities of global piriformis syndrome treatment market.
Data Bridge Market Research analyses a growth rate in the global piriformis syndrome treatment market in the forecast period 2022-2029. The expected CAGR of global piriformis syndrome treatment market is tend to be around 6% in the mentioned forecast period. The market was valued at USD 240 million in 2021, and it would grow upto USD 382.52 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Piriformis Syndrome Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Medication, Physical Therapy, Osteopathic Manipulative Treatment (OMT), Prolotherapy, Surgery, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Lilly (U.S.), Amgen Inc. (U.S.), Hainan Poly Co. Ltd (China), WOCKHARDT (India)
|
|
Market Opportunities
|
|
Market Definition
Piriformis syndrome is a type of medical condition typically characterized by buttock pain caused by a problem with piriformis muscle, located deep in the buttock under the gluteus maximus. Patients suffering from the piriformis often experience pain, tingling sensation and numbness in the buttocks and down the leg. This disease prevalence is rising and essential diagnostic procedures and treatments will boost the growth of the market.
Global Piriformis Syndrome Treatment Market Dynamics
Drivers
- Increased Piriformis Syndrome
According to a study report published on Medscape in December 2018, the prevalence ratio of piriformis syndrome is 6 women to 1 man in the U.S. Furthermore, the occurrence of piriformis syndrome in patients with sciatica is 6% in the country. A study was conducted at a local hospital in the U.S., revealing that out of the 750 patients with lower back problem (LBP), 45 suffered from piriformis syndrome. The study update on NCBI states that the estimated new cases of back pain and sciatica is 40 million per year, and occurrence rate of piriformis syndrome is about 2.4 million per year. This is boosting the market growth.
- Growing Demand for Hospitals and Clinics
The demand for hospitals and clinics are rising high due to the rising number of the piriformis syndrome patients that increases the number of treatments in the hospitals & clinics. This is the primary driver expected to boost the market's growth during the forecast period.
Opportunities
- Higher Adoption of Physical Therapy
The area of physical therapy is expected to rise high during the forecast period. Post a piriformis syndrome diagnosis, the patient should be recommended to refrain from the offending activities and begin physical therapy treatment. Physical Therapy if combined with stretching and manual therapy, it leaves a great benefit to the patients. All these factors are also contributing in the growth of the market.
- The Wide Application of Generic Drugs
Branded drug manufacturers and generic producing firms are joining up together for the production of generic drugs after patent expiry, which is projected to lift the growth of generics. In addition, major firms are gradually focusing on developing generics due to the increase in off-patented drugs in the market. Although, marketing exclusivity given by the FDA to patent holders for several indications is predicted to hamper market growth to a slight extent.
Restraints/Challenges
- Higher Expenditure Associated With Gastroenteritis Treatment
High-end expenditure regarding the drug manufacturing and development process are hampering the market's growth. High initial investment required in the R&D activities for developing vaccines, drugs, and kits used in the treatment are restraining growth of the global piriformis syndrome treatment market.
- Unavailability of Appropriate Treatments
To treat conditions that are rare, many times, all treatments are not available, especially in the under-developed countries. The severe patients needs to be treated with advanced techniques but at times, these are not available in the hospitals and clinics. Thus, it hampers the market growth.
This global piriformis syndrome treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global piriformis syndrome treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Piriformis Syndrome Treatment Market Scope
The global piriformis syndrome treatment market is segmented on the basis of treatment, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Medication
- Physical Therapy
- Osteopathic Manipulative Treatment (OMT)
- Prolotherapy
- Surgery
- Others
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Piriformis Syndrome Treatment Market Regional Analysis/Insights
The global piriformis syndrome treatment market is analysed and market size insights and trends are provided by treatment, end-user, distribution channel as referenced above.
The major countries covered in the global piriformis syndrome treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is considered to have the highest lucrative growth in the forecast period due to the high prevalence of piriformis syndrome and large availability of treatment options
Asia-Pacific is dominating the market due to the presence of key generic pharmaceuticals companies in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Piriformis Syndrome Treatment Market Share Analysis
The global piriformis syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global piriformis syndrome treatment market.
Key players operating in the global piriformis syndrome treatment market include:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Merck & Co., Inc. (U.S.)
- Lilly (U.S.)
- Amgen Inc. (U.S.)
- Hainan Poly Co. Ltd (China)
- WOCKHARDT (India)
SKU-